Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

Key Terms

over-the-counter regulatory

Over-the-counter describes securities or trades that occur directly between buyers and sellers rather than on a formal stock exchange. Think of it like buying at a flea market instead of a big supermarket: prices, rules and transparency can vary, which can mean lower liquidity, wider price swings and less regulatory oversight—factors investors watch because they affect ease of trading and risk level.

glucose biosensor medical

A glucose biosensor is a medical device that measures the amount of sugar in a small blood or interstitial fluid sample and displays a numerical reading, like a fuel gauge for the body’s glucose level. Investors care because these sensors drive recurring sales (sensors, test strips, reader devices), influence healthcare costs and patient outcomes, and face regulatory approval and reimbursement decisions that directly affect a company’s revenue and growth prospects.

macronutrients medical

Macronutrients are the main types of nutrients—proteins, carbohydrates, and fats—that provide the body with energy and the building blocks for growth and repair. For investors, macronutrient composition matters because it drives consumer choices, product labeling, reformulation, and regulatory scrutiny in food, supplement and health sectors; think of macronutrients as a product’s recipe that can change demand, costs and compliance risk.

metabolic health medical

Metabolic health describes how well a person’s body turns food into energy and keeps blood sugar, cholesterol, blood pressure, weight and inflammation in healthy ranges. It matters to investors because poor metabolic health drives demand for drugs, medical devices, diagnostics and wellness services, raises healthcare costs and affects workforce productivity—think of it as the engine efficiency of a population that influences market size and future earnings.

behavioral science technical

Behavioral science studies how real people actually make decisions and act, including predictable mistakes, habits, and social influences, rather than how they would behave in idealized models. For investors it matters because these human patterns shape consumer demand, employee performance, product adoption, marketing effectiveness and market sentiment—think of it like traffic rules and signs that steer behavior: understanding them helps predict outcomes and design strategies that work with, not against, real-world human behavior.

AI-enabled technical

AI-enabled describes a product, service, or process that uses artificial intelligence—software that learns from data and makes decisions or predictions—as a core feature rather than a minor add-on. For investors it matters because AI-enabled offerings can boost productivity, lower costs or unlock new revenue streams; like adding a smart autopilot to a routine task, they can change a company's growth potential and competitive edge while also bringing higher upfront investment needs and distinct regulatory or ethical risks.

• Enhanced Smart Food Logging experience now provides nutritional breakdown of meals
• Advanced AI-enabled features will deliver easy meal tracking to transform daily metabolic health management
• Redesigned and personalized Daily Insights will reveal how daily performance and behaviors impact health

SAN DIEGO--(BUSINESS WIRE)-- Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take steps in achieving their long-term health goals. The newest features will launch nationwide in the coming weeks.

Enhanced Smart Food Logging experience now provides nutritional breakdown of meals

Last year, Dexcom introduced AI-driven Smart Food Logging in Stelo, the first over-the-counter glucose biosensor cleared¹ by the FDA in the United States. Now the company has expanded this feature by integrating a comprehensive nutrition database that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more, for each logged meal, helping users better understand how food impacts their glucose and empowering them to make more informed dietary decisions. The database includes over one million food options with multiple ways to log a meal, including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution.

“When we launched Smart Food Logging last summer, our goal was to provide users with a simple and effective way to consistently log meals and understand how those meals had an impact on their glucose,” said Girish Naganathan, executive vice president and chief technology officer at Dexcom. “We listened closely to the feedback and are excited to further enhance this highly requested feature in Stelo. The latest update will eliminate nutrition tracking friction so users can make informed, health-conscious decisions and achieve health goals with even greater confidence.”

Understanding the role of macronutrients such as carbohydrates, proteins, and fats is essential for maintaining healthy glucose levels. After using Stelo for 30 days, the majority of users indicated positive changes in their dietary and eating patterns, and improvements in physical activity and weight-management habits.^2,3 By learning how different foods and specific macronutrients impact glucose levels with Stelo, users will be empowered with even more information to better understand and manage their metabolic health.

"Living with type 2 diabetes has forced me to slow down and pay attention to my health," said Mike Golic Sr., sports broadcaster, former professional football defensive tackle and Stelo ambassador. "Before Stelo, I was guessing how different foods affected my glucose—now I actually know. What excites me most about the latest update to Smart Food Logging is that it’s going to make managing my health even more seamless. This isn't just about better technology—it's about giving people the information to stay ahead of their metabolic health instead of always playing catch-up.”

Stelo will also launch a redesigned Daily Insights feature which will introduce a new interface with a sophisticated, card-based system. Users will receive up to three personalized recommendations based on their previous day's glucose, activity, nutrition, and sleep data. Each insight will highlight key individual metrics and provide contextual understanding.

A fourth card will use behavioral science techniques to help users reflect on and act upon their metabolic health insights. The feature uses AI to maintain day-over-day context, ensuring consistent and evolving personalized coaching that adapts to individual patterns and progress.

Stelo users will be able to access the enhanced Smart Food Logging and redesigned Daily Insights features by updating to the latest version of the app^* on iOS and Android platforms in the coming weeks.

Dexcom is bringing these new features to Stelo as it finishes development and regulatory approvals for a completely reimagined Stelo app experience, launching later this year.

To learn more about Stelo or to purchase, visit Stelo.com or Amazon.

About Dexcom

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

*Smart device sold separately. For Stelo app compatibility information, visit stelo.com/compatibility.

1 Dexcom, Stelo User Guide, 2024. 2 Crawford, M. (2025). Early Experiences with Stelo: Real-World Behavioral and Glycemic Outcomes in Users with Type 2 Diabetes, Prediabetes, or No Diabetes [Conference presentation abstract]. Eighty-Fifth scientific sessions of the American Diabetes Association, Chicago, IL, United States. https://doi.org/10.2337/db25-2020-LB 3 Dexcom, Data on File, 2025.

Category: IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20260204086490/en/

Media Contact

Janika Kelly

mediarelations@dexcom.com

Investor Contact

Sean Christensen

sean.christensen@dexcom.com

Source: Dexcom, Inc.